Clario is a leading provider of comprehensive endpoint technologies and solutions for clinical trial management. With a focus on transforming lives, Clario offers a wide range of services and expertise to accelerate clinical trials from initiation to implementation. Their innovative approach, backed by artificial intelligence and precision motion technologies, revolutionizes endpoint analyses and enhances data quality while expediting data collection processes. With a commitment to patient safety and well-being, Clario prioritizes the impact of treatments on mental health and daily functionality, ensuring the highest quality of life for patients participating in clinical trials.
With a team of hundreds of clinical trial management experts and extensive global regulatory experience, Clario provides certainty in the reliability and precision of their evidence generation technologies. Their comprehensive solutions cover various therapeutic areas, including cardiovascular, metabolic, dermatology, gastroenterology, hepatology, infectious diseases, musculoskeletal, neuroscience, oncology, ophthalmology, and respiratory. By offering precision endpoint technology, decentralized trial enablement, and cardiac safety support, Clario delivers more certain outcomes for virtual or hybrid trials. Through their collaborative approach to partnerships, Clario aims to transform the landscape of clinical trial management and improve the efficacy, safety, and quality of life for patients participating in oncology trials.
Generated from the website